Insightful Analysis on Economics, Markets & Global Affairs

  • EUR/USD
    Loading…
  • XAU/USD
    Loading…
  • USD/TRY
    Loading…
  • EUR/TRY
    Loading…
  • XAU/TRY
    Loading…
  • Brent Oil
    Loading…
  • S&P 500
    Loading…
  • UST Yield 10y
    Loading…
  • BIST 100
    Loading…
  • VIX
    Loading…

Trending

Visa and Mastercard spent years lobbying against Brazil's free payment app

Jul 22, 2026

Brazil's Pix handles 80% of the population's payments for free. Now the Trump administration is using tariffs to push back on behalf of US card companies.

Chubb made $2.84 billion last quarter insuring your worst fears

Jul 22, 2026

Chubb's booming profit shows that demand for protection against disasters, cyberattacks, and financial ruin is growing fast and so are the premiums.

Latest

Chubb's booming profit shows that demand for protection against disasters, cyberattacks, and financial ruin is growing fast and so are the premiums.

Chubb made $2.84 billion last quarter insuring your worst fears

Chubb's booming profit shows that demand for protection against disasters, cyberattacks, and financial ruin is growing fast and so are the premiums.

Chubb made $2.84 billion last quarter insuring your worst fears

The world's largest shipping firm is charging more per box starting August 1, because Hormuz tensions just spiked fuel costs again.

CMA CGM just added $165 per container. Your shelves will feel it.

The world's largest shipping firm is charging more per box starting August 1, because Hormuz tensions just spiked fuel costs again.

CMA CGM just added $165 per container. Your shelves will feel it.

Hungary's OTP Bank wants to buy Luminor, a $18bn Baltic lender. Lithuania's regulator is asking why OTP still operates in Russia.

OTP's Russian problem just landed on the Baltics' biggest bank deal

Hungary's OTP Bank wants to buy Luminor, a $18bn Baltic lender. Lithuania's regulator is asking why OTP still operates in Russia.

OTP's Russian problem just landed on the Baltics' biggest bank deal

Nike is pulling its products off third-party online stores in China, betting that tighter brand control can reverse a 17% sales collapse.

Nike is cutting off its China distributors to win back Chinese shoppers

Nike is pulling its products off third-party online stores in China, betting that tighter brand control can reverse a 17% sales collapse.

Nike is cutting off its China distributors to win back Chinese shoppers

Brazil's Pix handles 80% of the population's payments for free. Now the Trump administration is using tariffs to push back on behalf of US card companies.

Visa and Mastercard spent years lobbying against Brazil's free payment app

Brazil's Pix handles 80% of the population's payments for free. Now the Trump administration is using tariffs to push back on behalf of US card companies.

Visa and Mastercard spent years lobbying against Brazil's free payment app

News Corp says Brave stole Wall Street Journal content to sell to AI companies. The countersuit puts a price on journalism's survival fight.

News Corp is suing Brave for $150,000 per article over AI scraping

News Corp says Brave stole Wall Street Journal content to sell to AI companies. The countersuit puts a price on journalism's survival fight.

News Corp is suing Brave for $150,000 per article over AI scraping

A heat wave, surprise plant failures, and razor-thin reserves pushed a central US grid to the edge of rolling blackouts Monday evening.

Power nearly went out across 14 states last night

A heat wave, surprise plant failures, and razor-thin reserves pushed a central US grid to the edge of rolling blackouts Monday evening.

Power nearly went out across 14 states last night

Tempus AI is acquiring Personalis and its technology that can detect microscopic traces of cancer after treatment, but investors aren't convinced on the price.

Tempus just paid $1.5 billion for a cancer test that reads your blood

Tempus AI is acquiring Personalis and its technology that can detect microscopic traces of cancer after treatment, but investors aren't convinced on the price.

Tempus just paid $1.5 billion for a cancer test that reads your blood